Icosavax, Inc.
ICVX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $315 | $411 | $101 | $358 |
| - Cash | $59 | $279 | $13 | $23 |
| + Debt | $9 | $0 | $5 | $0 |
| Enterprise Value | $265 | $132 | $92 | $335 |
| Revenue | $1 | $8 | $2 | $0 |
| % Growth | -92.5% | 382.8% | – | – |
| Gross Profit | -$1 | $8 | -$16 | -$4 |
| % Margin | -216.7% | 98.9% | -993.3% | – |
| EBITDA | -$94 | -$65 | -$19 | -$5 |
| % Margin | -16,185.2% | -831.9% | -1,146.2% | – |
| Net Income | -$88 | -$68 | -$19 | -$5 |
| % Margin | -15,199% | -871.6% | -1,187.2% | – |
| EPS Diluted | -2.23 | -3.78 | -6.67 | -0.51 |
| % Growth | 41% | 43.3% | -1,207.8% | – |
| Operating Cash Flow | -$62 | -$39 | -$14 | -$5 |
| Capital Expenditures | -$11 | -$1 | -$0 | $0 |
| Free Cash Flow | -$73 | -$40 | -$14 | -$5 |